Myomo (MYO) Preferred Dividend Payments (2016 - 2017)
Myomo (MYO) posted Preferred Dividend Payments of $13768.0 for Q4 2017, down 94.42% on a QoQ basis from $246827.0 in Q2 2017, and down 97.61% year-over-year from $576739.0 in Q4 2016.
Myomo (MYO) Preferred Dividend Payments (2016 - 2017) Analysis & Trends
Myomo's Preferred Dividend Payments history runs 2 years deep, the most recent figure standing at $13768.0 for Q4 2017.
- Quarterly Preferred Dividend Payments fell 97.61% year-over-year to $13768.0 in Q4 2017, while the trailing twelve-month figure through Dec 2017 was $422470.0 (changed N/A YoY) and the FY2017 annual result came in at $287779.0, down 56.28% from the prior year.
- Preferred Dividend Payments was $13768.0 for Q4 2017 at Myomo, down from $246827.0 in the prior quarter.
- Across five years, Preferred Dividend Payments topped out at $576739.0 in Q4 2016 and bottomed at $13768.0 in Q4 2017.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Pref Dividends (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | - |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | - |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | - |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | - |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | - |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | - |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Myomo | 39.24 Mn | 20.27 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2017 | 13,768.00 |
| Jun 30, 2017 | 246,827.00 |
| Mar 31, 2017 | 161,875.00 |
| Dec 31, 2016 | 576,739.00 |
| Sep 30, 2016 | 27,187.00 |